The global airway management devices market is projected to reach USD 2.4 Billion by 2028 from USD 1.8 Billion in 2022, at a CAGR of 5.6% during the forecast period. The growth of this market is majorly driven by increasing demand for emergency and intensive care units, increasing growth in healthcare infrastructure development and rising pre-term birth population is supporting the growth of the market. However, dearth of skilled professional for airway management procedures may restrain the market growth during the forecast period.
Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=116806061
Based on type, the airway management devices market has been segmented into infraglottic devices, supraglottic devices, laryngoscopes, resuscitators, cricothyrotomy kits, and other airway management devices. The Infraglottic airway management devices segment accounted for the largest market share in 2022. Increasing number of surgical procedures and emergency care is driving the adoption of infraglottic devices in the market.
Based on patient age, the airway management devices market has been categorized into adult patients and pediatric /neonatal patients. In 2022, adult patients segment dominates the segment due to increasing prevalence of chronic diseases in geriatric population.
Based on applications, the airway management devices market is segmented into anesthesia, emergency medicine and others. The anesthesia application segment is expected to observe highest growth rate during the forecast period which can be attributed to the growing need for maintaining a safe breathing passage to decrease the risk of anesthesia-related complications during surgery.
Based on end users, the airway management devices market is segmented into hospitals, ambulatory care settings, home-care settings, and others. Hospital & diagnostic centers observe the highest growth rate during the forecast period attributed to the growing number of emergency care and intensive care beds across hospitals worldwide.
Based on the region segmentation, the airway management devices market is divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America holds the largest share and expects to dominate the airway management devices market. Growth in the North American market is mainly driven by increasing number of favorable reimbursement policies investments and rising number of acute and ambulatory care settings.
Major Players:
Medtronic (Ireland), ICU Medical, Inc. (US), Teleflex Incorporated (US), Ambu A/S (Denmark), ConvaTec Group Plc (UK), KARL STORZ SE & CO. KG (Germany), Flexicare Group Ltd. (UK), Intersurgical Ltd. (UK), SunMed LLC (US), Vyaire (US), Verathon Inc. (US), Sourcemark LLC (US), VBM Medizintecnik GmBH (Germany), Mercury Enterprises (US), Atos Medical (Sweden), P3 Medical (UK), Henan Tuoren Medical Device Co. Ltd. (China), BOMImed (Canada), Mederen Neotech Ltd. (Israel), and Medis Medical (UK) Ltd.(China), Olympus Corporation (Japan), Armstrong Medical Ltd. (Eakin Healthcare Group) (UK), Nihon Kohden Corporation (Japan) and Shenzen Hugemed Medical Technical Development Co. Ltd. (China)
Recent Developments
In 2022, SunMed Holdings (US) announced a strategic partnership with Securisyn Medical LLC (US) to enhance ventilated patient safety and broader smooth tube and catheter security.
In 2022, Coloplast A/S acquired Atos Medical to add a new chronic business segment – ENT & Respiratory Care, which will run as a separate strategic unit, operating on shared Coloplast infrastructure.
In 2022, ICU Medical, Inc. acquired Smiths Medical (US), which includes a syringe and ambulatory infusion devices, vascular access, and vital care products. When combined with ICU Medical’s existing businesses, it created a leading infusion therapy company.
